Q2 2024 Holdings
Filed 2024-08-14 | 92 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $64.9M | 3,645,562 | 5.7% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $60.5M | 7,548,000 | 5.3% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $45.1M | 141,499 | 4.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $42.9M | 2,055,916 | 3.8% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $39.7M | 7,293,728 | 3.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $33.7M | 4,947,738 | 3.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $33.2M | 856,178 | 2.9% |
| Surmodics Inc(SU6) | COM | 868873100 | $32.9M | 781,777 | 2.9% |
| Organogenesis Hldgs Inc(ORGO) | COM | 68621F102 | $32.3M | 11,518,954 | 2.8% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $29.0M | 1,276,190 | 2.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $24.4M | 694,069 | 2.1% |
| Axogen Inc(AXGN) | COM | 05463X106 | $23.9M | 3,305,815 | 2.1% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $23.1M | 126,000 | 2.0% |
| Merus N V | COM | N5749R100 | $22.3M | 376,321 | 2.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $22.2M | 123,450 | 2.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $22.1M | 4,210,537 | 2.0% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $22.0M | 533,015 | 1.9% |
| Celcuity Inc(CELC) | COM | 15102K100 | $19.8M | 1,211,187 | 1.7% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $19.7M | 408,373 | 1.7% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $19.6M | 137,700 | 1.7% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $18.7M | 4,051,996 | 1.7% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $18.6M | 853,628 | 1.6% |
| Neuropace Inc(NPCE) | COM | 641288105 | $18.4M | 2,433,168 | 1.6% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $18.0M | 769,263 | 1.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $17.4M | 71,700 | 1.5% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $17.0M | 826,500 | 1.5% |
| Humana Inc(HUM) | COM | 444859102 | $16.6M | 44,356 | 1.5% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $16.0M | 415,000 | 1.4% |
| Treace MED Concepts Inc(TMCI) | COM | 89455T109 | $15.7M | 2,365,648 | 1.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $14.0M | 185,250 | 1.2% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $14.0M | 719,000 | 1.2% |
| CG Oncology Inc(CGON) | COM | 156944100 | $13.4M | 424,585 | 1.2% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $13.0M | 171,788 | 1.1% |
| Evolus Inc(EOLS) | COM | 30052C107 | $12.5M | 1,152,000 | 1.1% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $10.4M | 799,546 | 0.9% |
| Alector Inc(ALEC) | COM | 014442107 | $10.2M | 2,239,006 | 0.9% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $10.1M | 221,600 | 0.9% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $9.5M | 586,499 | 0.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $9.4M | 170,741 | 0.8% |
| Biodesix Inc | COM | 09075X108 | $9.4M | 6,111,964 | 0.8% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $9.0M | 1,049,895 | 0.8% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $8.9M | 309,500 | 0.8% |
| Rigel Pharmaceuticals Inc(RIGL) | COM | 766559702 | $8.6M | 1,043,697 | 0.8% |
| Bausch Health COS Inc(BHC) | COM | 071734107 | $8.4M | 1,206,000 | 0.7% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $8.1M | 7,293,007 | 0.7% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $7.8M | 647,982 | 0.7% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $7.5M | 800,000 | 0.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $7.5M | 399,430 | 0.7% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $7.2M | 509,000 | 0.6% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $7.1M | 201,000 | 0.6% |